ATOSSA THERAPEUTICS, INC. Operating Lease Liability
ATOSSA THERAPEUTICS, INC. (ATOS) had Operating Lease Liability of $0 as of 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2023-03-22
- 2022-12-31: Operating Lease, Liability $0.00.
- 2022-09-30: Operating Lease, Liability $0.00.
- 2022-06-30: Operating Lease, Liability $0.00.
- 2022-03-31: Operating Lease, Liability $0.00.
| Period end | Operating Lease, Liability |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-22 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-07 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-08 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-07 |
| 2019-01-01 | $101.00K 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |